developed
c
obtained
compared
b
eight
exposed
tests
analyses
l
two
cg
cells
p
oral
yearold
hospital
months
patients
loss
inflammatory
diagnosed
produced
different
occurs
presence
pe
region
value
assess
results
amino
unknown
diagnostic
cases
mg
demonstrated
ct
elevated
genetic
isolated
suggest
may
human
af
include
factors
metabolic
infections
additional
leading
common
degrees
genes
resulting
resulted
active
molecular
quantitative
potential
significantly
detected
good
assessed
examined
using
used
sn
levels
rats
subsequent
mrna
indicate
produce
structures
regulation
ca
controls
suggested
systems
groups
functional
characteristics
current
work
derived
tested
however
nuclear
cs
showed
concentrations
assays
action
diseases
moreover
particular
free
appears
mean
performance
transcription
pcd
type
mouse
therapeutic
therapy
selected
treated
years
surgical
techniques
procedure
conditions
exposure
nucleus
period
occurred
identify
us
particularly
activation
production
ib
dependent
tumor
considered
primary
investigation
muscle
young
women
stage
long
weeks
responses
research
risk
dysfunction
pressure
signaling
related
aa
rates
field
result
overall
reduce
multiple
improved
water
essential
induced
healthy
tps
sc
lung
approach
individual
initial
nerve
individuals
known
family
cellular
agent
enhanced
cd
days
g
length
determined
concentration
novel
acids
components
effective
mechanisms
csd
l1
interaction
hours
ra
survival
short
caused
amount
would
nm
rather
selective
binding
mutant
improvement
process
even
provide
provides
especially
size
physiological
peak
pattern
heart
exp
r
led
probably
animal
disease
antigen
control
cm
x
surface
blood
required
indicated
without
complications
many
various
later
patient
followup
number
information
regions
addition
acid
cr
identified
se
outcome
relative
remains
purpose
death
enzyme
synthesis
range
severe
highly
age
still
daily
dna
need
early
hormone
prior
main
among
values
key
cell
methods
investigated
content
types
reaction
relationship
role
chemical
effects
suggests
either
andor
neurons
anterior
surgery
c2
induction
local
animals
activity
subjects
decrease
reduction
might
t0
highest
comparison
show
infection
importance
literature
part
e
correlated
calculated
demonstrate
standard
testing
determine
whether
furthermore
pcr
sensitivity
samples
mice
remained
greater
biological
shows
induce
time
involved
recently
differentiation
od
left
pd
first
protein
vivo
studied
purified
analyzed
species
indicating
distinct
features
dp
frequently
treatment
life
changes
lead
impact
signal
method
measurements
brain
manner
mgkg
marked
markers
play
involvement
directly
bone
administration
specifically
rat
cultured
paper
recorded
average
whole
variety
aim
characterized
pet
sd
ability
appeared
order
difference
ps
containing
mediated
little
sites
mass
recent
basal
secretion
taken
events
vs
independent
discussed
corresponding
model
increase
three
group
technique
ml
versus
proteins
skin
rare
revealed
due
findings
performed
week
t3
studies
ec
acute
basis
year
evidence
high
h
structural
established
responsible
specificity
possible
although
disorder
syndrome
injection
test
erp
diagnosis
confirmed
doses
increased
ie
ga
gene
exhibited
several
carried
large
thus
proliferation
use
response
causes
proposed
management
describe
simple
effect
new
as
means
higher
solution
influence
rate
significant
differences
four
conclusion
able
ce
negative
via
receptors
damage
expression
support
limited
seen
ss
evaluated
pr
cause
peptide
mm
intracellular
based
medium
consistent
end
strongly
incidence
alternative
population
ratio
area
rapid
rna
respectively
useful
medical
alterations
renal
knowledge
reported
lower
factor
contrast
form
formation
occur
positive
whereas
antibody
development
arterial
estimated
growth
defined
single
presented
following
rpa
affected
site
likely
cp
poor
ip
enzymes
plays
female
combination
pathway
tissues
specific
processes
major
receptor
stress
capacity
similar
frequency
lack
improve
series
inhibitors
activities
functions
underlying
st
investigate
injury
i.t.
hypothesis
applied
cardiac
compare
state
hr
calcium
molecules
accumulation
change
microscopy
despite
stimulated
pathways
low
fraction
seven
lt
modified
altered
min
experiments
upon
rho
extent
chronic
times
six
pulmonary
cf
volume
resistance
total
less
tissue
report
case
duration
level
one
rt
found
another
also
structure
data
associated
better
present
study
reduced
po
disorders
within
relatively
dose
necessary
collected
strains
analysis
five
association
observed
well
clinical
including
decreased
stimulation
according
previous
care
condition
review
membrane
normal
ph
parameters
metabolism
bb
sp
described
drugs
available
male
increases
lesions
absence
suggesting
plasma
mainly
direct
failure
properties
uptake
inhibited
could
drug
liver
together
measured
body
weight
index
evaluate
system
virus
vitro
detection
n
electron
c1
approximately
fold
achieved
pt
shown
therefore
critical
density
underwent
made
imaging
mics
markedly
degree
contained
inhibitor
much
interactions
throughout
ii
often
forms
carcinoma
important
increasing
children
component
cl
patterns
included
since
across
strong
application
complex
flow
received
phase
second
small
cancer
expressed
course
sample
examine
agents
lines
health
conducted
provided
previously
tau
ad
per
models
day
kidney
antibodies
function
contribute
products
immune
serum
mechanism
concluded
understanding
followed
kinase
assessment
finally
target
release
develop
given
inhibition
nc
conclude
examination
assay
maximum
objective
status
combined
affect
correlation
laboratory
mortality
temperature
majority
least
mutations
located
